Journal Article

Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell‐Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury

Nagoshi, Narihito, Miyoshi, Hiroyuki, Sugai, Keiko, Fukuzawa, Ryuji, Shibata, Shinsuke, Matsumoto, Morio, Ozaki, Masahiro, Kawabata, Soya, Iida, Tsuyoshi, Kohyama, Jun, Yasutake, Kaori, Renault‐Mihara, Francois, Nakamura, Masaya, Kojima, Kota, Itakura, Go, Ito, Shuhei, Okano, Hideyuki

2019

Overview

Tumorigenesis is an important problem that needs to be addressed in the field of human stem/progenitor cell transplantation for the treatment of subacute spinal cord injury (SCI). When certain “tumorigenic” cell lines are transplanted into the spinal cord of SCI mice model, there is initial improvement of motor function, followed by abrupt deterioration secondary to the effect of tumor growth. A significant proportion of the transplanted cells remains undifferentiated after transplantation and is thought to increase the risk of tumorigenesis. In this study, using lentiviral vectors, we introduced the herpes simplex virus type 1 thymidine kinase (HSVtk) gene into a human induced pluripotent stem cell‐derived neural stem/progenitor cell (hiPSC‐NS/PC) line that is known to undergo tumorigenic transformation. Such approach enables selective ablation of the immature proliferating cells and thereby prevents subsequent tumor formation. In vitro, the HSVtk system successfully ablated the immature proliferative neural cells while preserving mature postmitotic neuronal cells. Similar results were observed in vivo following transplantation into the injured spinal cords of immune‐deficient (nonobese diabetic–severe combined immune‐deficient) mice. Ablation of the proliferating cells exerted a protective effect on the motor function which was regained after transplantation, simultaneously defending the spinal cord from the harmful tumor growth. These results suggest a potentially promising role of suicide genes in opposing tumorigenesis during stem cell therapy. This system allows both preventing and treating tumorigenesis following hiPSC‐NS/PC transplantation without sacrificing the improved motor function. Stem Cells Translational Medicine 2019;8:260&270 The herpes simplex virus thymidine kinase (HSVtk) gene was introduced into a tumorigenic cell line of human induced pluripotent stem cell‐derived neural stem/progenitor cells (hiPSC‐NS/PCs) prior to transplantation into spinal cord injury mouse models. Administration of ganciclovir (GCV) following transplantation successfully ablated the immature tumorigenic cells while preserving the mature neuronal cells and the improved motor function.

• Publisher: John Wiley & Sons, Inc,Oxford University Press
• Subject: Ablation / Animals / Apoptosis / Carcinogenesis - pathology / Cell cycle / Cell Differentiation - physiology / Cells, Cultured / Cytotoxicity / Diabetes mellitus / Disease Models, Animal / Enabling Technologies for Cell‐Based Clinical Translation / Female / Genes / Herpes simplex / Herpes simplex virus thymidine kinase / Herpes viruses / Human induced pluripotent stem cell‐derived neural stem/progenitor cell / Humans / Induced Pluripotent Stem Cells - cytology / Medical research / Mice / Mice, Inbred NOD / Mice, SCID / Neural stem cells / Neural Stem Cells - cytology / Neurons - physiology / Pharmaceutical industry / Pluripotency / Progenitor cells / Recovery of Function - physiology / Scientific equipment and supplies industry / Spinal Cord - physiology / Spinal cord injuries / Spinal Cord Injuries - therapy / Spinal cord injury / Stem cell research / Stem cell therapy / Stem cell transplantation / Stem Cell Transplantation - methods / Stem cells / Suicide / Suicide gene / Suicide genes / Tetracycline / Tetracyclines / Thymidine / Thymidine kinase / Transplantation / Tumorigenesis / Tumors